246 results on '"Slonimskaya E"'
Search Results
2. Breast tumour cell subpopulations with expression of the MYC and OCT4 proteins
3. VHL Expression in Kidney Cancer: Relation to Metastasis Development, Transcription and Growth Factors and Component of Akt/m-TOR Signaling Pathway
4. Integral characteristic of the immune system state predicts breast cancer outcome
5. Changes in the Activity of Proteasomes and Calpains in Metastases of Human Lung Cancer and Breast Cancer
6. Transcription factors NF-kB, HIF-1, HIF-2, growth factor VEGF, VEGFR2 and carboanhydrase IX mRNA and protein level in the development of kidney cancer metastasis
7. Effect of Target Therapy on the Content of Transcription and Growth Factors, Protein Kinase TOR, and Activity of Intracellular Proteases in Patients with Metastatic Renal Cell Carcinoma
8. Chymotrypsin-like activity and subunit composition of proteasomes in human cancers
9. Dynamics of aberrant methylation of functional groups of genes in progression of breast cancer
10. 70P A DNA methylation markers panel for prediction of luminal B breast cancer neoadjuvant chemotherapy response by quantitative PCR
11. Proteasome activity in tumors of the female reproductive system
12. Analysis of the Density Characteristics of Giant Cell Bone Tumors Treated with Denosumab According to CT Findings
13. PI3K/AKT/MTOR: CONTRIBUTION TO THE TUMOR PHENOTYPE SENSITIVE TO TAMOXIFEN
14. Changes in Proteasome Chymotrypsin-Like Activity during the Development of Human Mammary and Thyroid Carcinomas
15. Aberrations of the number of copies (CNA) in the genome of luminal B breast tumor
16. 23P Different profile of receptor tyrosine kinases expression in breast cancer molecular subtypes
17. ROLE OF CYCLIN D1 IN THE MECHANISMS OF TAMOXIFEN RESISTANCE
18. 94P Coexpression of PI3K/Akt signaling components and breast stem cells markers: Potential contributions in resistance to tamoxifen treatment
19. 93P IRF4 gene promoter methylation predicts efficacy of luminal B breast tumours neoadjuvant chemotherapy
20. ASSOCIATION OF THE COMBINATION OF STEMNESS GENE AMPLIFICATIONS AND COPY NUMBER ABERRATIONS OF WNT-SIGNALING GENES IN BREAST TUMORS WITH METASTASIS
21. The role of epidermal growth factor receptor (EGFR) in the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer patients
22. Integral characteristic of the immune system state predicts breast cancer outcome
23. The Effect of Presynthesized Powder Additives in Combined Synthesis and Sintering of SrZrO3 Ceramics
24. SYNERGISTIC APPROACH TO SINTERING BINARY OXIDE MIXTURES FOR PRODUCTION OF SRZRO3-BASED CERAMICS
25. Ceramics Based on Strontium Zirconate (A Review)
26. Prediction of distant metastases in breast cancer from blood flow in primary nodule estimated using kinetic analysis of 99Tcm-MIBI uptake
27. The prognostic significance of BRCA1 gene expression in patients with breast cancer
28. Capabilities of preoperative targeted therapy in treatment of bone metastases in renal cancer
29. RESPONSE TO NEOADYAVANT CHEMOTHERAPY WITH PLATINUM-BASED DRUGS IN BREAST CANCER PATIENTS WITH BRCA1 DELETION IN TUMOR
30. Monocytes and cancer: promising role as a diagnostic marker and application in therapy
31. Association between the molecular markers, effect and time of response to the androgen-deprivation therapy in patients with prostate cancer
32. 24. Non-invasive quantification of 99Tcm-MIBI extraction by mammary cancer
33. Relation of EGFR/PI3K/AKT signaling components with tamoxifen efficacy in patients with estrogen-dependent breast cancer
34. Individual approach to choosing an appropriate regimen of adjuvant hormone therapy in patients with early-stage breast cancer
35. TRIM16 transcription factor in prostate cancer
36. IMPACT OF TRANSCRIPTION FACTORS, VEGF AND PROTEASES ON KIDNEY CANCER PROGRESSION
37. BRCA1 mRNA expression levels as an predictor of response to neoadjuvant chemotherapy in breast cancer
38. The clinical observation of human papillomavirus positive breast tumor
39. TRANSCRIPTION FACTOR BRN-3α AND PROSTATE CANCER, RELATION WITH HORMONE RECEPTORS AND AKT/M-TOR SIGNALING PATHWAY ACTIVATION
40. GENOME-WIDE ASSOCIATION STUDY OF LOSS OF HETEROZYGOSITY AND METASTASIS-FREE SURVIVAL IN BREAST CANCER PATIENTS
41. Prognosis method to predict small-sized breast cancer affected by fibrocystic disease
42. TEN-YEAR OUTCOMES AFTER BREAST-CONSERVING SURGERY WITH INTRAOPERATIVE RADIOTHERAPY FOR BREAST CANCER
43. Impact of prognostic factors for postmastectomy radiation therapy of breast cancer patients
44. Transcription factor Brn-3α mRNA in cancers, relationship with AR, ER receptors and AKT/m-TOR pathway components
45. Non-Smad TGF-β signaling components are possible biomarkers of tamoxifen resistance
46. Features of proteasome functioning in malignant tumors
47. Copy number aberrations landscape of a breast tumor, connection with the efficiency of neoadjuvant chemotherapy
48. ROLE OF TRANSFORMING GROWTH FACTOR RECEPTOR B I TYPE (TGF-BRI) IN THE PROGRESSION OF THE LUMINAL BREAST CANCER SUBTYPE
49. Chemotherapy changes cytotoxic activity of NK-cells in cancer patients
50. Nuclear medicine in breast cancer diagnostics: Primary tumor and lymphatic metastasis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.